Albinterferon alfa-2b dosed every two or four weeks in interferon-naive patients with genotype 1 chronic hepatitis C

Stefan Zeuzem; Eric Yoshida; Yves Benhamou; Stephen Pianko; Vincent G Bain; Daniel Shouval; Robert Flisiak; Vratislav Rehak; Mircea Grigorescu; Kelly Katia; Patrick W Cronin; Erik Pulkstenis; G Mani Subramanian; John G McHutchison

doi:10.1002/hep.22403

Albinterferon alfa-2b dosed every two or four weeks in interferon-naive patients with genotype 1 chronic hepatitis C

Stefan Zeuzem, Eric Yoshida, Yves Benhamou, Stephen Pianko, Vincent G Bain, Daniel Shouval, Robert Flisiak, Vratislav Rehak, Mircea Grigorescu, Kelly Katia, Patrick W Cronin, Erik Pulkstenis, G Mani Subramanian, John G McHutchison

Medicine Monash Health

Research output: Contribution to journal › Article › Research › peer-review

82 Citations (Scopus)

Original language	English
Pages (from-to)	407 - 417
Number of pages	11
Journal	Hepatology
Volume	48
Issue number	2
DOIs	https://doi.org/10.1002/hep.22403
Publication status	Published - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/hep.22403

Cite this

Zeuzem, S., Yoshida, E., Benhamou, Y., Pianko, S., Bain, V. G., Shouval, D., Flisiak, R., Rehak, V., Grigorescu, M., Katia, K., Cronin, P. W., Pulkstenis, E., Subramanian, G. M., & McHutchison, J. G. (2008). Albinterferon alfa-2b dosed every two or four weeks in interferon-naive patients with genotype 1 chronic hepatitis C. Hepatology, 48(2), 407 - 417. https://doi.org/10.1002/hep.22403

@article{5e4c2cf7901745cab3d5b1d75678f097,

title = "Albinterferon alfa-2b dosed every two or four weeks in interferon-naive patients with genotype 1 chronic hepatitis C",

author = "Stefan Zeuzem and Eric Yoshida and Yves Benhamou and Stephen Pianko and Bain, {Vincent G} and Daniel Shouval and Robert Flisiak and Vratislav Rehak and Mircea Grigorescu and Kelly Katia and Cronin, {Patrick W} and Erik Pulkstenis and Subramanian, {G Mani} and McHutchison, {John G}",

year = "2008",

doi = "10.1002/hep.22403",

language = "English",

volume = "48",

pages = "407 -- 417",

journal = "Hepatology",

issn = "0270-9139",

publisher = "John Wiley & Sons",

number = "2",

}

Zeuzem, S, Yoshida, E, Benhamou, Y, Pianko, S, Bain, VG, Shouval, D, Flisiak, R, Rehak, V, Grigorescu, M, Katia, K, Cronin, PW, Pulkstenis, E, Subramanian, GM & McHutchison, JG 2008, 'Albinterferon alfa-2b dosed every two or four weeks in interferon-naive patients with genotype 1 chronic hepatitis C', Hepatology, vol. 48, no. 2, pp. 407 - 417. https://doi.org/10.1002/hep.22403

TY - JOUR

T1 - Albinterferon alfa-2b dosed every two or four weeks in interferon-naive patients with genotype 1 chronic hepatitis C

AU - Zeuzem, Stefan

AU - Yoshida, Eric

AU - Benhamou, Yves

AU - Pianko, Stephen

AU - Bain, Vincent G

AU - Shouval, Daniel

AU - Flisiak, Robert

AU - Rehak, Vratislav

AU - Grigorescu, Mircea

AU - Katia, Kelly

AU - Cronin, Patrick W

AU - Pulkstenis, Erik

AU - Subramanian, G Mani

AU - McHutchison, John G

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/record/display.url?eid=2-s2.0-49649089488&origin=inward&txGid=XVPCMosuMlC6mg2BKxb1CS5%3a30

U2 - 10.1002/hep.22403

DO - 10.1002/hep.22403

M3 - Article

SN - 0270-9139

VL - 48

SP - 407

EP - 417

JO - Hepatology

JF - Hepatology

IS - 2

ER -

Albinterferon alfa-2b dosed every two or four weeks in interferon-naive patients with genotype 1 chronic hepatitis C

UN SDGs

Access to Document

Other files and links

Cite this